OBJECTIVES: To estimate the prevalence of @entity66 in aged care facilities, and the relationship between cognitive or @entity717 and significant disease. SETTING: 2 large aged care facilities in Auckland, New Zealand, each providing low and high level care. @entity1 : All 161 residents of the facilities were invited to participate. The only exclusion criterion was inability to obtain consent from the individual or designated guardian. 88 @entity1 were recruited-66 females (75%), 22 males (25%) with average age 87.1   years (SD 5.5   years). PRIMARY AND SECONDARY OUTCOME MEASURES: Primary-presence of significant @entity272 (defined as that which in the opinion of the investigators needed treatment or was identified as a @entity1 concern) diagnosed clinically on full dermatological examination by a dermatologist or dermatology trainee. Secondary-functional and cognitive status (Rehabilitation Complexity Scale and Abbreviated Mental Test Score). RESULTS: 81.8% were found to have at least one significant condition. The most common disorders were @entity6313 42 (47.7%), @entity1491 13 (14.8%), @entity484 11 (12.5%) and @entity957 in situ 9 (10.2%). Other findings were @entity957 7 (8%), bullous pemphigoid 2 (2.3%), @entity320 2 (2.3%), @entity3854 (2.3%) and @entity0 (1.1%). @entity32 was more common in those with @entity717 compared with those with serious @entity717 (OR 3.69; 95% CI 1.1 to 12.6, p=0.04). No significant association was found between @entity272 and @entity73 . CONCLUSIONS: A high rate of @entity66 was found. Findings ranged from frequent but not life-threatening conditions (eg, @entity6313 ), to those associated with a significant morbidity (eg, @entity484 , @entity3854 and bullous pemphigoid), to potentially life-threatening (eg, @entity957 , @entity320 and @entity0 ). Those with less significant @entity73 were found to be at greater risk of inflammatory dermatoses.

XXXX in the older age group: a cross-sectional study in aged care facilities.

@entity1 :: ('9606', 'Species') :: ['patient', 'PARTICIPANTS', 'participants'] @entity3854 :: ('MESH:D018459', 'Disease') :: ['lichen sclerosus 2', 'lichen sclerosus'] @entity32 :: ('MESH:D007249', 'Disease') :: ['Inflammatory disease'] @entity66 :: ('MESH:D004194', 'Disease') :: ['dermatological disease'] @entity484 :: ('MESH:D004485', 'Disease') :: ['asteototic eczema', 'eczema'] @entity0 :: ('MESH:D001943', 'Disease') :: ['breast cancer', 'carcinoma of the breast 1'] @entity73 :: ('MESH:D003072', 'Disease') :: ['cognitive impairment', 'physical impairment'] @entity957 :: ('MESH:D002294', 'Disease') :: ['invasive squamous cell carcinoma', 'squamous cell carcinoma'] @entity6313 :: ('MESH:D014009', 'Disease') :: ['onychomycosis'] @entity272 :: ('MESH:D012871', 'Disease') :: ['skin disease'] @entity717 :: ('MESH:D009069', 'Disease') :: ['physical disability', 'little physical disability'] @entity320 :: ('MESH:D008545', 'Disease') :: ['melanoma'] @entity1491 :: ('MESH:D002280', 'Disease') :: ['basal cell carcinoma']
@entity66 :: (MESH:D004194,Disease) :: ['Dermatological disease']
